SCHEMBL4209706

SCHEMBL4209706

CC(C)(C)OC(=O)ON1CCC[C@@H]1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
EP300 Q09472 6/20 0.53
CREBBP Q92793 6/20 0.53
SCN3A Q9NY46 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
USP2 O75604 1/20 0.48
RHOC P08134 1/20 0.47
RHOA P61586 1/20 0.47
PTPN2 P17706 1/20 0.45
PTPN1 P18031 1/20 0.45
PTPN6 P29350 1/20 0.45
POLB P06746 1/20 0.44
HCRTR1 O43613 1/20 0.44
HCRTR2 O43614 1/20 0.44
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CCR1 P32246 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27693623 0.86 EP300 (0.54) NPC1EP300CREBBPSCN3AMEN1
SCHEMBL78329 0.81 NPC1 (0.77) NPC1EP300CREBBPMEN1KMT2A
SCHEMBL4206705 0.79 F10 (0.48) NPC1MEN1KMT2A
SCHEMBL6987515 0.78 GPR119 (0.50) NPC1MEN1KMT2APTPN2PTPN1
SCHEMBL7493948 0.74 MEN1 (0.39) MEN1KMT2AUSP2ALDH1A1L3MBTL1
SCHEMBL27754721 0.73 FKBP1A (0.41) NPC1POLBRAB9A
SCHEMBL27614912 0.73 HSD17B10 (0.45) NPC1RAB9AALDH1A1
SCHEMBL27614915 0.73 HSD17B10 (0.45) NPC1RAB9AALDH1A1
SCHEMBL17729048 0.73 ALDH1A1 (0.63) NPC1MEN1KMT2AUSP2RHOC
SCHEMBL8283575 0.72 PTPN2 (0.81) NPC1RHOCRHOAPTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720844-B1 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2009-04-29 EP disclosed
EP-1791597-A2 CARBONYL COMPOUND-CONTAINING DRUG AND THE USE THEREOF Merck Patent GmbH (DE) 2007-06-06 EP disclosed
EP-1720844-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GmbH (DE) 2006-11-15 EP disclosed
WO-2006032342-A2 CARBONYL COMPOUND-CONTAINING DRUG AND THE USE THEREOF MERCK PATENT GMBH (DE) 2006-03-30 WO disclosed
WO-2004087646-A2 PYRROLIDINO-1,2-DICARBOXY-1-(PHENYLAMIDE)-2-(4-(3-OXO-MORPHOLINO-4-YL)-PHENYLAMIDE) DERIVATIVES AND RELATED COMPOUNDS FOR USE AS INHIBITORS OF COAGULATION FACTOR XA IN THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2004-10-14 WO disclosed